COMP <GO>
BDX vs UNH // REVENUE GROWTH (YOY)
Becton Dickinson and Company (NYSE) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: BDX 6
— UNH 8
▲ REVENUE GROWTH (YOY) LEADER: BDX
LAST: $198.60 (+0.36%) • MKT CAP: $54.10B
revenue-growth
8.20%
LAST: $400.44 (-1.60%) • MKT CAP: $359.43B
revenue-growth
3.33%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BDX VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BDX | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 45.40% | 88.31% | -42.91 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 4.90% | 12.38% | -7.48 | UNH | /roic <GO> |
| EV/EBITDA & P/E Valuation | 21.8x | 15.3x | +6.53 | UNH | /valuation <GO> |
| Free Cash Flow Yield | 2.13% | 6.25% | -4.12 | UNH | /fcf-yield <GO> |
| Operating Margin | 11.80% | 5.32% | +6.48 | BDX | /operating-margins <GO> |
| Net Profit Margin | 7.70% | 3.53% | +4.17 | BDX | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 8.20% | 3.33% | +4.87 | BDX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.21% | 2.29% | -0.08 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.22 | 3.09 | -0.87 | UNH | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | BDX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 7.00% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 64.5 | 55.1 | +9.40 | BDX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.06 | 0.33 | +0.73 | BDX | /macro-sensitivity <GO> |
| Forward P/E Multiple | 29.9x | 17.7x | +12.16 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $54.10B | $359.43B | -$305.34B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BDX REV | UNH REV | BDX GROSS % | UNH GROSS % | BDX FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $21.84B | $447.57B | 45.4% | 88.7% | — | $16.07B |
| FY 2024 | $20.18B | $400.28B | 45.2% | 88.3% | — | $20.70B |
| FY 2023 | $19.37B | $371.62B | — | 89.6% | — | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BDX // BETA 1.06
UNH // BETA 0.33